Vahid Rahimian, DO
Allergy · Elmhurst, NYNPI 1659683902
Payments from drug & device makers
Across 1,035 payments — averaging $27.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$9K
- GSK$5K
- AstraZeneca$4K
- Regeneron Healthcare Solutions, Inc.$2K
- Novartis$1K
- Genentech USA, Inc.$1K
- plus $5K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 120 | $9,447 |
| GSK | 332 | $5,183 |
| AstraZeneca | 129 | $4,296 |
| Regeneron Healthcare Solutions, Inc. | 53 | $1,628 |
| Novartis | 78 | $1,436 |
| Genentech USA, Inc. | 102 | $1,192 |
| Amgen | 25 | $760 |
| Pfizer | 44 | $618 |
| AbbVie | 19 | $594 |
| Optinose US, Inc. | 23 | $498 |
| CSL Behring | 22 | $481 |
| Sanofi-aventis U.S. LLC | 14 | $369 |
| Boehringer Ingelheim | 3 | $267 |
| Kaleo, Inc. | 13 | $258 |
| Alk-abello, Inc | 12 | $224 |
| Incyte Corporation | 6 | $198 |
| Aimmune Therapeutics, Inc. | 7 | $132 |
| Lilly USA, LLC | 4 | $80 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Organon | 3 | $58 |
| Galderma Laboratories, L.p. | 3 | $54 |
| LEO Pharma Inc. | 3 | $51 |
| Covis Pharma GmbH | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Pharming Healthcare, Inc. | 2 | $39 |
| Mylan Specialty L.p. | 2 | $34 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Biocryst US Sales Co., LLC | 1 | $23 |
| Novo Nordisk | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $18 |
How this compares
$28,210 in reported general payments places this provider in the 80th percentile of 92 allergy providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Elmhurst
- Audrey WeissmanElmhurst$36K
- Juan Abel Romero LoorElmhurst$3K
- Christopher SmithHorseheads$18M
- Marc BraunsteinHewlett$924K
- Allison RamseyRochester$904K
- Dariusz ChrostowskiWatertown$751K
- Anne MaitlandTarrytown$626K
- Yudhistira PersaudBronx$280K
- Alan KaufmanMount Vernon$227K
- Michael KatlanAlbany$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.